From Yahoo Finance: 2025-05-16 15:08:00

Jim Cramer warns investors are avoiding Johnson & Johnson due to legal concerns related to talcum powder and Robert Kennedy Jr.’s criticisms. Despite JNJ’s strong balance sheet and drug pipeline, uncertainty looms over potential legal risks, deterring investors. JNJ currently yields 3.55%, but the legal overhang raises doubts.

Johnson & Johnson is a healthcare company known for producing and selling medical products. While JNJ has growth potential, some believe AI stocks offer higher returns with less risk. For those seeking AI stocks with greater promise than JNJ, a report on the cheapest AI stock with 100x upside potential is recommended.

These articles provide further insights into stock analysis: “Jim Cramer Put These 8 Stocks Under a Microscope Recently” and “Jim Cramer Commented on These 6 Natural Gas Players.” Disclosure: None.

Read more: Jim Cramer Notes That “People Are Staying Away From” Johnson & Johnson